Horalix Presents AI Echocardiography at Future Leaders Summit 2025
NEWS | December 21, 2025 | Sarajevo, Bosnia and Herzegovina
Horalix presented its AI echocardiography workflow software at Future Leaders Summit 2025, connecting clinical AI with Sarajevo’s innovation ecosystem.
Short answer
Horalix participated in Future Leaders Summit 2025 from December 19 to 21, 2025, at Hotel Hills in Sarajevo, Bosnia and Herzegovina. The team presented its AI-assisted echocardiography workflow software and spoke with students, founders, engineers, diaspora professionals, healthcare stakeholders, and regional innovation partners.
What is Future Leaders Summit?
Future Leaders Summit is an annual event organized by the Bosnia and Herzegovina Futures Foundation to connect emerging leaders with education, technology, industry, and the global Bosnian and Herzegovinian community.
The official FLS 2025 program took place over three days at Hotel Hills and included keynote presentations, panel discussions, workshops, company visits, exhibitions, and networking activities.
Its program covered areas including:
- Science and engineering
- Artificial intelligence
- Healthcare and longevity
- Entrepreneurship
- Leadership
- Professional development
- Technology and innovation
- Bosnia and Herzegovina’s global diaspora
For Horalix, this created an opportunity to present a locally built healthcare technology product to a broad audience interested in the country’s future.
What Horalix presented at FLS 2025
Horalix presented its work on AI-assisted echocardiography workflow software for hospitals, cardiology departments, and diagnostic clinics.
Echocardiography uses ultrasound to examine the heart, but the work does not end when the images are acquired. Cardiologists and sonographers may still need to review clips, perform measurements, evaluate cardiac structures, organize findings, and prepare a report.
Horalix is building software to support this post-acquisition workflow by:
- Processing echocardiography DICOM studies
- Extracting structured cardiac measurements
- Preparing report-ready information
- Supporting visual review and verification
- Reducing repetitive manual work
- Keeping clinicians responsible for final interpretation
Visitors were able to learn how the Horalix CardiologyAI platform approaches workflow automation without removing the physician from clinical decision-making.
Why Horalix attended
Public technology events are important for a medical AI company because healthcare innovation cannot develop in isolation.
Building useful clinical software requires communication between:
- Clinicians
- Software engineers
- Artificial intelligence researchers
- Hospital administrators
- Regulatory and data-security specialists
- Investors
- Students and future technical talent
- International healthcare partners
At FLS 2025, Horalix used these conversations to explain why practical clinical AI must do more than generate predictions.
It must:
- Address a clearly defined clinical workflow
- Produce output that physicians can inspect
- Integrate with existing medical imaging systems
- Reduce operational friction
- Communicate evidence and limitations honestly
- Create measurable value for healthcare teams
Clinical AI built in Sarajevo
Horalix was founded in Sarajevo and is developing technology intended for use across European and international healthcare environments.
This is strategically important for Bosnia and Herzegovina.
The country is widely recognized for software engineering and technical talent, but companies such as Horalix are working to demonstrate that the region can also create its own specialized, export-oriented technology products.
AI echocardiography combines several areas in which local teams can build internationally relevant expertise:
- Medical imaging
- Machine learning
- Clinical workflow design
- Healthcare interoperability
- Data infrastructure
- Secure software deployment
- Human-centered product development
Horalix’s presence at FLS was therefore not only a company presentation. It was an example of a Sarajevo team attempting to build a focused healthcare product for a global market.
What Horalix learned from the event
The most valuable conversations were practical.
Participants asked how hospitals evaluate artificial intelligence, how clinicians verify measurements, how medical software integrates with existing systems, and how a startup from Bosnia and Herzegovina can expand into other European markets.
These discussions reinforced a central Horalix principle:
Clinical AI should reduce complexity for healthcare teams, not introduce more of it.
For Horalix, useful artificial intelligence means structured output, transparent review, reliable deployment, and a clear understanding of what the system can and cannot do.
Did Future Leaders Summit validate the Horalix product?
No.
Future Leaders Summit was an innovation, education, and networking event. Horalix’s participation increased visibility, created new relationships, and allowed the team to receive product and market feedback.
It was not a clinical trial, regulatory review, or independent technical validation.
Clinical evidence and product benchmarks are addressed separately through Horalix’s evidence disclosures, hospital evaluations, and clinical partnerships.
What comes next
Horalix continues to focus on:
- Clinical workflow evaluation
- Hospital and clinic pilots
- AI-assisted measurement extraction
- Structured echocardiography reporting
- DICOM-compatible deployment
- Partnerships across Bosnia and Herzegovina and Europe
Learn more about: